Valuation: Jilin Aodong Pharmaceutical Group Co., Ltd.

Market Cap 20.68B 3.05B 2.67B 2.46B 2.27B 4.31B 291B 4.39B 29.4B 11.55B 143B 11.45B 11.2B 493B P/E 2024
13.1x
P/E 2025 9.57x
Enterprise Value 19.96B 2.94B 2.57B 2.37B 2.19B 4.16B 281B 4.23B 28.37B 11.14B 138B 11.05B 10.81B 475B EV / Sales 2024
7.76x
EV / Sales 2025 9.49x
Free-Float
67.59%
Yield 2024
2.9%
Yield 2025 2.56%
06-09 China Approves Aodong Subsidiary's Levocarnitine Injection MT
05-21 Jilin Aodong Pharmaceutical Gets China Approval for Supplemental Registration of Heart Drug MT
05-12 Jilin Aodong Pharmaceutical Group Co., Ltd. Approves Final Cash Dividend on A Shares for the Year 2025, Payable on 08 July 2026 CI
04-29 Jilin Aodong Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
04-20 Jilin Aodong Pharmaceutical's Attributable Profit Jumps 54% in 2025 MT
04-17 Jilin Aodong Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025 CI
02-12 Aodong Pharmaceutical's Subsidiary Gets Nod to Market 10 Traditional Chinese Medicines MT
01-26 Beijing Sun-Novo Pharmaceutical Research Co., Ltd. cancelled the acquisition of Jiangsu Langyan Life Technology Holdings Co., Ltd. from Li Qian, Ganzhou Langyi Investment Center (Limited Partnership) and Other shareholders. CI
25-10-30 Jilin Aodong Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025 CI
25-10-21 Aodong Pharmaceutical Gets China Supplementary Nod for Anti-Opioid Medication MT
25-09-22 Jilin Aodong Pharmaceutical Group Co., Ltd. Approves Interim Cash Dividend on A Shares for 2025, Payable on October 22, 2025 CI
25-09-01 Jilin Aodong Pharmaceutical Group Co., Ltd. Proposes Interim Profit Distribution Plan for 2025 CI
25-08-29 Jilin Aodong Yanbian Pharmaceutical Co., Ltd. announced that it expects to receive CNY 134.393064 million in funding from Jilin Aodong Pharmaceutical Group Co., Ltd. CI
1 day-1.07%
1 week-4.55%
Current month-0.51%
1 month+1.44%
3 months-3.29%
6 months-13.23%
Current year-9.68%
1 week 17.32
Extreme 17.32
18.7
1 month 17.08
Extreme 17.08
18.88
Current year 16.36
Extreme 16.36
20.93
1 year 16.36
Extreme 16.36
22.08
3 years 12.49
Extreme 12.49
22.08
5 years 12.49
Extreme 12.49
22.08
10 years 12.49
Extreme 12.49
29.43
Manager TitleAgeSince
Chief Executive Officer 63 2017-07-16
Director of Finance/CFO 49 2004-04-30
Director of Finance/CFO 54 2007-06-17
Director TitleAgeSince
Chairman 73 2005-05-17
Director/Board Member 63 2000-01-31
Chairman 59 2017-07-16
Date Insider Type Main position Quantity % Market Cap.
11-24Buy 100 0.0000%
24-07-28Buy

Chief Executive Officer

320,000 0.0276%
24-07-28Buy

Chairman

350,000 0.0302%
Change 5-day change 1-year change 3-year change Capi.($)
-1.07%-4.55%-0.62%+12.43% 3.05B
+0.08%-1.10%+48.48%+173.03% 1,060B
+0.12%-0.45%+64.63%+62.57% 619B
-0.31%-2.61%+29.55%+85.72% 438B
-0.70%+0.81%+29.80%+25.00% 333B
+0.26%-0.40%+29.21%+47.28% 282B
-1.39%-10.13%+18.85%+22.67% 267B
+0.23%+0.31%-27.33%-38.40% 218B
-1.11%-1.56%+21.44%+58.44% 196B
-0.54%-0.29%+15.29%+68.47% 161B
Average -0.36%-3.60%+22.93%+51.72% 357.7B
Weighted average by Cap. -0.12%-3.10%+35.84%+84.30%

Financials

2024 2025
Net sales 2.61B 385M 337M 311M 287M 544M 36.72B 554M 3.71B 1.46B 18.09B 1.45B 1.41B 62.19B 2.34B 344M 301M 278M 257M 487M 32.85B 495M 3.32B 1.3B 16.18B 1.29B 1.26B 55.63B
Net income 1.55B 229M 200M 185M 170M 324M 21.82B 329M 2.21B 866M 10.75B 859M 840M 36.96B 2.4B 353M 309M 285M 263M 499M 33.69B 508M 3.41B 1.34B 16.6B 1.33B 1.3B 57.06B
Net Debt -386M -56.92M -49.79M -45.93M -42.42M -80.49M -5.43B -81.84M -549M -215M -2.67B -214M -209M -9.19B -724M -107M -93.4M -86.15M -79.57M -151M -10.18B -154M -1.03B -404M -5.02B -401M -392M -17.25B
Logo Jilin Aodong Pharmaceutical Group Co., Ltd.
Jilin Aodong Pharmaceutical Group Co., Ltd. specializes in the manufacturing and marketing of pharmaceutical products. Besides, the group offers food products. Net sales break down by activity as follows: - sale of pharmaceutical products (89.4%); - sale of food products (6.8%); - other (3.8%). All sales are in China.
Employees
5,461
Date Price Change Volume
26-07-10 CN¥17.64 -1.07% 14,006,300
26-07-09 CN¥17.83 +0.73% 12,360,059
26-07-08 CN¥17.70 -1.99% 10,420,598
26-07-07 CN¥18.06 -3.73% 13,183,515
26-07-06 CN¥18.76 +1.52% 18,041,470

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 000623 Stock